DANIELA MAXIM: Open Payments
NPI 1962892307 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,565 in 186 payments from 22 companies in 2025. Trend: 2023 $27,564 · 2024 $29,839 · 2025 $13,565
Speaker / faculty: $7,305Food & beverage: $4,550Consulting: $760Travel & lodging: $704Education: $247
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 19 | $4,034 |
| Regeneron Healthcare Solutions, Inc. | 23 | $3,143 |
| GENZYME CORPORATION | 25 | $2,289 |
| UCB, Inc. | 12 | $1,171 |
| Janssen Biotech, Inc. | 33 | $836 |
| Novartis Pharmaceuticals Corporation | 9 | $406 |
| LEO Pharma Inc. | 12 | $339 |
| Incyte Corporation | 8 | $190 |
| ABBVIE INC. | 12 | $168 |
| Amgen Inc. | 3 | $162 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, TREMFYA, Rhapsido, OPZELURA, ADBRY, ANZUPGO.
Industry payments across MI — which companies pay providers there.
